Indications and uses
To treat cold sores/fever blisters. To help guard against infection.
To treat cold sores/fever blisters. To help guard against infection.
Using only warm water and a washcloth, clean the lip area of any lip preparations, lotions, ointments, residual beverages, or cosmetics, including lipstick. Remove the cardboard cap from the applicator end and place the cardboard cap onto the glass/plastic vial end, opposite the brush end of the product. Squeeze the cardboard cap to break open the inner glass vial. Saturate the applicator end with solution by hold...
Store at room temperature. The ingredients in toothpaste, soft drinks, and some fruit juices can deactivate the active ingredient in Blister Blaster. For best results, avoid brushing your teeth with toothpaste or drinking soft drinks or fruit juices for at least one hour after applying the drug.
Drug Facts
Benzalkonium Chloride 0.13%
Cold Sore/Fever Blister Treatment Topical Antiseptic
Do not use:
Stop use and ask a doctor if:
Ask a doctor if:
When using this product you may feel a brief stinging sensation when you apply it. The sting should go away in a short time.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Store at room temperature. The ingredients in toothpaste, soft drinks, and some fruit juices can deactivate the active ingredient in Blister Blaster. For best results, avoid brushing your teeth with toothpaste or drinking soft drinks or fruit juices for at least one hour after applying the drug.
Isopropyl alcohol (70% v/v), water.
Questions or to report an adverse event: 1-877-825-7153
NDC 66774-1001-2
blisterblaster®
One Day,
One Dose,
Healing Begins.
Finally, a cold sore treatment that actually
works—so you can clear away that THING
on your lip right now!
Relieves Pain and Burning
Not available through retail stores; avoid imitations.
Contents: 2 Vials (0.6 ml)

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1049254 | benzalkonium chloride 0.13 % Topical Solution | PSN | 1 |
| 1116098 | blisterblaster 0.13 % Topical Solution | PSN | 1 |
| 1116098 | benzalkonium chloride 1.3 MG/ML Topical Solution [Blister Blaster] | SBD | 1 |
| 1049254 | benzalkonium chloride 1.3 MG/ML Topical Solution | SCD | 1 |
| 1049254 | benzalkonium chloride 0.13 % Topical Solution | SY | 1 |
| 1116098 | Blister Blaster 0.13 % Topical Solution | SY | 1 |
| 1116098 | Blister Blaster 1.3 MG/ML Topical Solution | SY | 1 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66774-1001-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8956-f424-e053-dadaa90a57ce | blisterblaster ® |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66774-1001-2 | Blister Blaster | 2 in 1 BLISTER PACK | LIQUID | 2 | 1 | |
| 66774-1001-2 | Blister Blaster | 0.6 mL in 1 VIAL | LIQUID | 0.6 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66774-1001 | BLISTER BLASTER (BENZALKONIUM CHLORIDE) LIQUID [QUADEX PHARMACEUTICALS, LLC] | 1 | Legacy NDC, 2 package rows | 20110714_3481c8f5-6efe-4e57-b562-50385262f47b.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzalkonium chloride | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| Benzalkonium | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| Isopropyl Alcohol | INACTIVE INGREDIENT | ND2M416302 | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 66774-1001 | 66774-1001-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Benzalkonium chloride | F5UM2KM3W7 | ACTIB |
| Isopropyl Alcohol | ND2M416302 | IACT |
| Water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / AURICULAR (OTIC) | 6 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 06ab05e1-e358-4cfe-b092-e5eacf629918 | 3481c8f5-6efe-4e57-b562-50385262f47b | 2011-07-08 | Warnings | 06ab05e1-e358-4cfe-b092-e5eacf629918 3481c8f5-6efe-4e57-b562-50385262f47b |
Adverse event summaries are temporarily unavailable. Other product information remains available.